Mini reviews in medicinal chemistry · 2026
Pharmacological Profile of Thymoquinone: From Cellular Pathways to Nutraceutical Potential.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gyaneshwari Upagya, Swati Kumari, Prakash Anand, Pandey Brijesh
Аннотация
INTRODUCTION: Food-derived biomolecules offer high safety, accessibility, and therapeutic potential. Nigella sativa, particularly its bioactive terpenoid Thymoquinone (TQ), exhibits various pharmacological profile, including antioxidant, anti-inflammatory, and anticancer properties. This review summarizes the mechanistic roles of TQ in disease modulation and evaluates its potential for nutraceutical and pharmaceutical development.
METHODS: A systematic search of Google Scholar, PubMed, Scopus, Web of Science, and SciFinder (1990-2025) identified studies on the mechanism of action of TQ in cellular pathways, such as Wnt and JAK/STAT, and in redox reactions, along with clinical/preclinical models. The keywords used as filters were: Thymoquinone, anticancer, antioxidant, Nigella sativa, hepatoprotectant, neuroprotectant, cardioprotectant, nephroprotectant, and COVID-19.
RESULTS: TQ effectively modulates cell cycle arrest, ROS, and apoptosis. Significant dosage variability (30 mg/kg/day to 5000 mg/kg/day) exists across models, where emerging evidence suggests TQdeficient plant parts are an underexplored resource for TQ biosynthesis.
DISCUSSION: TQ has high translational value as a non-toxic adjuvant to conventional therapies, potentially reducing chemotherapy side effects and improving metabolic outcomes. However, clinical adoption requires standardized dosing and improved bioavailability through novel formulation strategies.
CONCLUSION: As a versatile lead compound for chronic disease management, future TQ research should prioritize standardizing dosage protocols, exploring alternative plant parts for optimize resource use, and developing high-bioavailability nutraceutical formulations to enhance therapeutic delivery.
METHODS: A systematic search of Google Scholar, PubMed, Scopus, Web of Science, and SciFinder (1990-2025) identified studies on the mechanism of action of TQ in cellular pathways, such as Wnt and JAK/STAT, and in redox reactions, along with clinical/preclinical models. The keywords used as filters were: Thymoquinone, anticancer, antioxidant, Nigella sativa, hepatoprotectant, neuroprotectant, cardioprotectant, nephroprotectant, and COVID-19.
RESULTS: TQ effectively modulates cell cycle arrest, ROS, and apoptosis. Significant dosage variability (30 mg/kg/day to 5000 mg/kg/day) exists across models, where emerging evidence suggests TQdeficient plant parts are an underexplored resource for TQ biosynthesis.
DISCUSSION: TQ has high translational value as a non-toxic adjuvant to conventional therapies, potentially reducing chemotherapy side effects and improving metabolic outcomes. However, clinical adoption requires standardized dosing and improved bioavailability through novel formulation strategies.
CONCLUSION: As a versatile lead compound for chronic disease management, future TQ research should prioritize standardizing dosage protocols, exploring alternative plant parts for optimize resource use, and developing high-bioavailability nutraceutical formulations to enhance therapeutic delivery.